Methods and systems for aneurysm stabilization and treatment
Devices and methods are described for delivering aneurysm stabilizing substances that may act in more than one pathway to the aneurysmal wall to prevent further enlargement of an aneurysm while allowing blood flow through the treatment area. Methods, devices and features for removal of the delivery device after the treatment are also disclosed.
1. An intravascular device for treating an aneurysm and delivering a substance to the aneurysm, the device comprising:
an insertion catheter;
a stent comprising a distal end and a proximal end and a length extending between the proximal end and the distal end, and wherein the stent is operable to be inserted within an artery;
wherein at least one of the distal end and the proximal end of the stent is permanently attached to the distal end of the insertion catheter by substantially rigid guide wires;
the stent comprising an inlet operable to receive blood flow at the distal end and an outlet operable to allow the egress of blood flow at the proximal end;
wherein the stent comprises a continuous expandable membrane provided between the distal end and the proximal end that is operable to expand and make continuous contact with an interior portion of an artery from the distal end to the proximal end to treat an aneurysm in the artery and secure the stent relative to the artery, the expandable membrane being operable to deliver a drug or substance to an aneurysm external to the stent; and
wherein the distal end of the stent is permanently connected to a distal end of an inner member of the insertion catheter by a plurality of substantially rigid guide wires and the proximal end of the stent is permanently connected to an outer member of the insertion catheter by a second plurality of substantially rigid guide wires.
2. The intravascular device of claim 1 , wherein the expandable membrane comprises at least one aneurysmal stabilizing substance that is selected from the group consisting of:
(a) therapeutic agents inhibiting elastin, collagen and/or hyaluronan degradation and/or restoring or improving their production and deposition selected from the group consisting of tannins, polyphenols and related agents, elastase inhibitors, collagenase inhibitors, hyaluronidase inhibitors, inhibitors of cysteine proteinases, inhibitors of cathepsins, inhibitors of calpain, inhibitors of serine proteinases and enhancers of LOX/LOXL production and/or activity;
(b) therapeutic agents inhibiting/modulating inflammation in the aortic wall selected from the group consisting of lymphocyte function suppressors, luekotriene receptor inhibitors, nf-kb inhibitors, prostaglandin/leukotriene antagonists and synthesis inhibitors/modulators, immunomodulatory/anti-inflammatory cannabinoids, sphingosine-1-phosphate receptor modulators and agents that reduce free radical damage selected from the group consisting of antioxidants, free radical scavengers, oxidative stress modulators, statins and boosters of cellular NAD+ levels; and
(c) therapeutic agents inhibiting apoptosis of cells in the aortic wall selected from the group consisting of inhibitors of caspases.
3. The intravascular device of claim 1 , wherein the stent comprises a single inlet operable to receive blood flow at the distal end and at least one outlet operable to allow the egress of blood flow at the proximal end, wherein the inlet of the stent comprises an area that is greater than the area of the at least one outlet of the stent, and wherein the expandable membrane is operable to be expanded at least in part by a force provided by a flow of blood entering the inlet of the stent.
4. The intravascular device of claim 1 , wherein the insertion catheter comprises an inner member and an outer member.
5. The intravascular device of claim 4 , wherein the inner member and the outer member are translatable relative to one another and wherein a translation of the inner member relative to the outer member is operable to expand and to collapse the stent.
6. The intravascular device of claim 4 , wherein the stent is secured to the inner member at the distal end of the stent and secured to the outer member at the proximal end of the stent.
7. The intravascular device of claim 1 , wherein a minimal outward radial force generated by the intravascular device is less than 10% of an outward radial force generated by the patient's own blood pressure.
8. The intravascular device of claim 1 , wherein at least a portion of the distal end and at least a portion of the proximal end of the stent are expandable between a first diameter and a second diameter.
9. An intravascular device for treating an aneurysm and delivering a substance to the aneurysm, the device comprising:
an insertion catheter;
a stent comprising a distal end and a proximal end and a length extending between the proximal end and the distal end, and wherein the stent is operable to be inserted within an artery;
wherein at least one of the distal end and the proximal end of the stent is permanently attached to the distal end of the insertion catheter by substantially rigid guide wires;
the stent comprising an inlet operable to receive blood flow at the distal end and an outlet operable to allow the egress of blood flow at the proximal end;
wherein the stent comprises a continuous expandable membrane provided between the distal end and the proximal end that is operable to expand and make continuous contact with an interior portion of an artery from the distal end to the proximal end to treat an aneurysm in the artery and secure the stent relative to the artery, the expandable membrane being operable to deliver a drug or substance to an aneurysm external to the stent;
wherein the insertion catheter comprises an inner member and an outer member and the inner member and the outer member are translatable relative to one another and wherein a translation of the inner member relative to the outer member is operable to expand and to collapse the stent.